Goldman Starts Team Health (TMH) at Conviction Buy, MEDNAX (MD) & IPC Hospitalist (IPCM) Neutral

April 4, 2013 8:55 AM EDT Send to a Friend
Get Alerts TMH Hot Sheet
Price: $58.42 -0.65%

Rating Summary:
    6 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 28 | New: 51
Trade TMH Now!
Join SI Premium – FREE
Goldman Sachs initiated coverage on Team Health (NYSE: TMH) with a Conviction Buy and a price target of $43.00. Analyst Brian Zimmerman said he was constructive on the PPM space and he believes the market will continue to support valuation multiples above historical averages.

"We highlight TMH as our top pick as we think its high uninsured volume mix makes it the largest beneficiary of healthcare reform and its scalable business model benefits from industry consolidation. Additionally, we initiate coverage on IPCM and MD with Neutral ratings. For IPCM, we think increased hospitalist competition and uncertainty around adding new providers balance the upside from post-acute expansion. For MD, we see slower growth in the core neonatal space and uncertainty around Medicaid parity offsetting its high-growth anesthesia opportunity," said Zimmerman.

For an analyst ratings summary and ratings history on Team Health (NYSE: TMH) click here. For more ratings news on Team Health click here.

Shares of Team Health closed at $36.75 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, New Coverage

Related Entities

Goldman Sachs

Add Your Comment